MemorialCare Long Beach Medical Center — Long Beach, California

Public research footprint of MemorialCare Long Beach Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

NSCLC (Advanced Non-small Cell Lung Cancer) · Heart Failure · Preeclampsia Severe · NSCLC (Non-small Cell Lung Carcinoma)

Recently updated registry entries

NCT07730268 — Vivio At-Home Study (Enrolling By Invitation)
NCT06881784 — Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) (Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at MemorialCare Long Beach Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.